Yesterday I introduced ApoE4a gene that approximately 75% of women during a study conducted at the San Francisco Veteran Affairs Medical Center did not have. They were looking at the effect that this gene would have on women after menopause; trying to determine whether or not the women with the gene would have changing effects on their carotid wall thickness which could potentially lead to the development or worsening atherosclerosis.
Tests proved that the use of estrogen therapy did not help nor hinder how thick the carotid artery walls were. However, the experts do feel as though ‘the thickening of the carotid arteries may cause mental deterioration by affecting blood flow to the brain.’
The theory seems quite plausible to those in the medical profession. It has been determined in the past that the area of the brain affected by AD (Alzheimer’s disease) is an area that also has quite a few estrogen receptors. They go on to quantify that if estrogen is administered in cases where Dementia has not already began developing, it could prove to be helpful in the prevention of the disease.
Although this information may prove helpful someday, right now it is still just general data sine there are no great preventatives for AD out there. Perhaps if those are determined, then the E4 status may become plausible.
Knowing about this is just basic information you can share with your clients. It is also good to know when accompanying them to their physician’s office so that you can ask good questions, too. Remember that the more that you know, the better off you will be in showing that With Age Comes Respect.